Functional promoter upstream p53 regulatory sequence of IGFBP3 that is silenced by tumor specific methylation -: art. no. 9

被引:41
作者
Hanafusa, T
Shinji, T
Shiraha, H
Nouso, K
Iwasaki, Y
Yumoto, E
Ono, T
Koide, N
机构
[1] Okayama Univ, Adv Sci Res Ctr, Dept Radiat Res, Shikata Lab, Okayama, Japan
[2] Okayama Univ, Grad Sch Med & Dent, Dept Lab Med, Okayama, Japan
[3] Okayama Univ, Grad Sch Med & Dent, Dept Internal Med 1, Okayama, Japan
[4] Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
关键词
D O I
10.1186/1471-2407-5-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Insulin-like growth factor binding protein (IGFBP)-3 functions as a carrier of insulin-like growth factors (IGFs) in circulation and a mediator of the growth suppression signal in cells. There are two reported p53 regulatory regions in the IGFBP3 gene; one upstream of the promoter and one intronic. We previously reported a hot spot of promoter hypermethylation of IGFBP-3 in human hepatocellular carcinomas and derivative cell lines. As the hot spot locates at the putative upstream p53 consensus sequences, these p53 consensus sequences are really functional is a question to be answered. Methods: In this study, we examined the p53 consensus sequences upstream of the IGFBP-3 promoter for the p53 induced expression of IGFBP-3. Deletion, mutagenesis, and methylation constructs of IGFBP-3 promoter were assessed in the human hepatoblastoma cell line HepG2 for promoter activity. Results: Deletions and mutations of these sequences completely abolished the expression of IGFBP-3 in the presence of p53 overexpression. In vitro methylation of these p53 consensus sequences also suppressed IGFBP-3 expression. In contrast, the expression of IGFBP-3 was not affected in the absence of p53 overexpression. Further, we observed by electrophoresis mobility shift assay that p53 binding to the promoter region was diminished when methylated. Conclusion: From these observations, we conclude that four out of eleven p53 consensus sequences upstream of the IGFBP-3 promoter are essential for the p53 induced expression of IGFBP-3, and hypermethylation of these sequences selectively suppresses p53 induced IGFBP-3 expression in HepG2 cells.
引用
收藏
页数:11
相关论文
共 28 条
[1]   Tumor necrosis factor alpha stimulates insulin-like growth factor binding protein 3 expression in cultured porcine Sertoli cells [J].
Besset, V ;
LeMagueresseBattistoni, B ;
Collette, J ;
Benahmed, M .
ENDOCRINOLOGY, 1996, 137 (01) :296-303
[2]   Further characterisation of the p53 responsive element - Identification of new candidate genes for trans-activation by p53 [J].
Bourdon, JC ;
DeguinChambon, V ;
Lelong, JC ;
Dessen, P ;
May, P ;
Debuire, B ;
May, E .
ONCOGENE, 1997, 14 (01) :85-94
[3]   INDUCTION OF THE GROWTH INHIBITOR IGF-BINDING PROTEIN-3 BY P53 [J].
BUCKBINDER, L ;
TALBOTT, R ;
VELASCOMIGUEL, S ;
TAKENAKA, I ;
FAHA, B ;
SEIZINGER, BR ;
KLEY, N .
NATURE, 1995, 377 (6550) :646-649
[4]   Mechanisms underlying lack of insulin-like growth factor-binding protein-3 expression in non-small-cell lung cancer [J].
Chang, YS ;
Wang, L ;
Suh, YA ;
Mao, L ;
Karpen, SJ ;
Khuri, FR ;
Hong, WK ;
Lee, HY .
ONCOGENE, 2004, 23 (39) :6569-6580
[5]  
Clemmons David R., 1997, Cytokine and Growth Factor Reviews, V8, P45, DOI 10.1016/S1359-6101(96)00053-6
[6]  
CUBBAGE ML, 1990, J BIOL CHEM, V265, P12642
[7]   Novel promoter polymorphism in insulin-like growth factor-binding protein-3: Correlation with serum levels and interaction with known regulators [J].
Deal, C ;
Ma, J ;
Wilkin, F ;
Paquette, J ;
Rozen, F ;
Ge, B ;
Hudson, T ;
Stampfer, M ;
Pollak, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) :1274-1280
[8]   Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells -: Relationship to transforming growth factor-β1 signaling [J].
Fanayan, S ;
Firth, SM ;
Baxter, RC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (09) :7255-7261
[9]   Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-β (TGF-β) and the type II TGF-β receptor [J].
Fanayan, S ;
Firth, SM ;
Butt, AJ ;
Baxter, RC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (50) :39146-39151
[10]   A mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumors [J].
Fraga, MF ;
Herranz, M ;
Espada, J ;
Ballestar, E ;
Paz, MF ;
Ropero, S ;
Erkek, E ;
Bozdogan, O ;
Peinado, H ;
Niveleau, A ;
Mao, JH ;
Balmain, A ;
Cano, A ;
Esteller, M .
CANCER RESEARCH, 2004, 64 (16) :5527-5534